Search results
Victoria Delgado
Research Area(s) / Expertise:
Author
Expertise
Heart FailureImaging & DiagnosticsInterventionStructural InterventionHeart Failure Diagnosis and ImagingCardiomyopathies and Cardiac AmyloidosisHeart Failure DevicesEchocardiography & UltrasoundCardiomyopathiesHypertrophic CardiomyopathyCT/MRIIntravascular ImagingEquity, Age, Sex, and ReproductionGenderDrug-eluting balloonsHeart Failure Services, Prevention and Digital HealthElectrophysiology & ArrhythmiaPeripheral InterventionCoronary InterventionsAtrial FibrillationCardiac AmyloidosisPrevention & Chronic ConditionsBifurcationChronic Heart Failure ManagementOther CardiomyopathiesCoronary Artery DiseaseTransradial InterventionAcute and Advanced Heart FailureLifestyleCoronary PhysiologyHeart Failure ComorbiditiesDemographic
Author(s):
Marat Fudim
Added:
1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat…
View more
Author(s):
Borja Ibanez
Added:
7 months ago
ESC Congress 2025 - REBOOT-MI finds that beta-blocker therapy after MI did not reduce the occurrence of adverse events in patients with LVEF greater than 40%.Dr Borja Ibanez (National Centre for Cardiovascular Research, Madrid, ES) joins us to discuss findings from REBOOT-CNIC (NCT03596385). The prospective, randomised, open-label trial investigated the benefits of long-term betablocker therapy…
View more
Biomarkers for Congestion in Heart Failure
Author(s):
Antonio Luca Maria Parlati
,
Cristina Madaudo
,
Vincenzo Nuzzi
,
et al
Added:
1 year ago
Review Article
Ton Duy Mai
Author
Stephen Dorman
Job title: Consultant Cardiologist
Author
Gérard Finet
Job title: MD, PhD
Author
James Burton
Research Area(s) / Expertise:
Author
Expertise
Heart FailureImaging & DiagnosticsInterventionStructural InterventionHeart Failure Diagnosis and ImagingCardiomyopathies and Cardiac AmyloidosisHeart Failure DevicesEchocardiography & UltrasoundCardiomyopathiesHypertrophic CardiomyopathyCT/MRIIntravascular ImagingEquity, Age, Sex, and ReproductionGenderDrug-eluting balloonsHeart Failure Services, Prevention and Digital HealthElectrophysiology & ArrhythmiaPeripheral InterventionCoronary InterventionsAtrial FibrillationCardiac AmyloidosisPrevention & Chronic ConditionsBifurcationChronic Heart Failure ManagementOther CardiomyopathiesCoronary Artery DiseaseTransradial InterventionAcute and Advanced Heart FailureLifestyleCoronary PhysiologyHeart Failure ComorbiditiesDemographic
Author(s):
Andrew Wang
Added:
5 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive…
View more
Gábor Széplaki
Job title: Electrophysiologist
Author